Showing results (211-220 of 291) with videos related to

Sort By:
Pageof 30
Breast (Edinburgh, Scotland)|May 2, 2021
Cost-effectiveness of postmastectomy hypofractionated radiation therapy vs conventional fractionated radiation therapy for high-risk breast cancerJing Yang, Shu-Nan Qi, Hui Fang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 13, 2021
A novel nomogram for predicting locoregional recurrence risk in breast cancer patients treated with neoadjuvant chemotherapy and mastectomyZhou Huang, Mei Shi, Wei-Hu Wang, et al.
Scientific Reports|October 20, 2024
Dosimetric benefit and clinical feasibility of deep inspiration breath-hold and volumetric modulated arc therapy-based postmastectomy radiotherapy for left-sided breast cancerShi-Jia Wang, Yi-Rui Zhai, Wen-Wen Zhang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 6, 2015
Survival benefit with IMRT following narrow-margin hepatectomy in patients with hepatocellular carcinoma close to major vesselsWei-Hu Wang, Zhi Wang, Jian-Xiong Wu, et al.
Therapeutic Advances in Medical Oncology|September 30, 2025
A recurrence risk score model evaluating effects of postmastectomy radiotherapy in breast cancer patients with pathologically negative lymph nodes after neoadjuvant chemotherapy: a multicenter, retrospective studyDan-Qiong Wang, Zhou Huang, Hong-Fen Wu, et al.
Practical Radiation Oncology|March 29, 2014
Epidemiologic study of compliance to postmastectomy radiation therapy guidelines in breast cancer patients in China between 1999 and 2008Shu-Lian Wang, Ye-Xiong Li, Bao-Ning Zhang, et al.
Plos One|February 4, 2014
Body mass index and breast cancer defined by biological receptor status in pre-menopausal and post-menopausal women: a multicenter study in ChinaJing Li, Yuan Huang, Bao-Ning Zhang, et al.
Clinical Breast Cancer|October 30, 2012
Epidemiologic study of radiotherapy use in China in patients with breast cancer between 1999 and 2008Shu-Lian Wang, Ye-Xiong Li, Bao-Ning Zhang, et al.
Blood|July 25, 2012
Clinical implications of plasma Epstein-Barr virus DNA in early-stage extranodal nasal-type NK/T-cell lymphoma patients receiving primary radiotherapyZhao-Yang Wang, Qing-Feng Liu, Hua Wang, et al.
British Journal of Cancer|March 25, 2023
The prognostic value of tumour-infiltrating lymphocytes, programmed cell death protein-1 and programmed cell death ligand-1 in Stage I-III triple-negative breast cancerGuang-Yi Sun, Jing Zhang, Bing-Zhi Wang, et al.
Pageof 30